The prognosis of patients with prostate cancer receiving permanent seed implantation stratified by prostate volume: Should we be reluctant to treat with brachytherapy because of a very small prostate (<15 cc)?
Koji Masui(Kyoto Prefectural University of Medicine), Shiro Saito(Tokyo Medical Center), Atsunori Yorozu(Tokyo Medical Center), Norihisa Katayama(Okayama University), Takashi Kikuchi(Translational Research Informatics Center (Japan)), Shinsuke Kojima(Translational Research Informatics Center (Japan)), Satoshi Higashide(Translational Research Informatics Center (Japan))
Cited by 1
Related Papers
Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy
|Molecular and Clinical Oncology|2016|79
Analysis of Factors Associated With Radiation-Induced Bronchiolitis Obliterans Organizing Pneumonia Syndrome After Breast-Conserving Therapy
|International Journal of Radiation Oncology*Biology*Physics|2008|69
Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study
|International Journal of Radiation Oncology*Biology*Physics|2015|43
Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival
|International Journal of Clinical Oncology|2018|32
Survival Outcomes of Treatment with Radiofrequency Ablation, Stereotactic Body Radiotherapy, or Sublobar Resection for Patients with Clinical Stage I Non–Small-Cell Lung Cancer: A Single-Center Evaluation
|Journal of Vascular and Interventional Radiology|2020|29